Related Experiment Video
Updated: Jun 1, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Vascular access in children on chronic hemodialysis: a Slovenian experience
Rina R Rus1, Gregor Novljan, Jadranka Buturović-Ponikvar
1Department of Pediatric Nephrology, University Medical Center, Ljubljana, Slovenia. rina.rus@guest.arnes.si
Insights
Arteriovenous fistulas (AVFs) are preferred for pediatric hemodialysis, but non-cuffed central venous catheters (CVCs) are a viable alternative when AVFs are not feasible. Both vascular access methods were evaluated in children with end-stage renal disease.
Area of Science:
- Nephrology
- Vascular Surgery
- Pediatrics
Background:
- End-stage renal disease (ESRD) necessitates hemodialysis (HD) in children and adolescents.
- Vascular access is crucial for effective HD treatment in pediatric patients.
- Arteriovenous fistulas (AVFs) and central venous catheters (CVCs) are common vascular access modalities.
Purpose of the Study:
- To evaluate the experience with arteriovenous fistulas (AVFs) and non-cuffed central venous catheters (CVCs) in pediatric patients undergoing hemodialysis.
- To compare the efficacy and complication rates of AVFs and CVCs in children with end-stage renal disease.
- To determine the suitability of these vascular accesses for long-term hemodialysis in a pediatric population.
Main Methods:
- Retrospective study of pediatric patients (≤18 years) with ESRD on HD between December 1998 and December 2010.
- Data collection on the creation, use, and outcomes of 35 AVFs and 77 non-cuffed CVCs.
- Analysis of primary failure rates, maturation times, patency, and bacteremia incidence.
Main Results:
- AVFs had a primary failure rate of 25.7%, with a mean maturation time of 4.0 months and mean patency of 42.5 months.
- Non-cuffed CVCs, primarily inserted in the jugular vein with citrate locking, had a bacteremia incidence of 0.9 episodes per 1000 catheter days.
- CVCs were used for an average of 3.6 months.
Conclusions:
- Native AVFs are the preferred vascular access for pediatric hemodialysis.
- Non-cuffed, jugular vein CVCs with citrate locking can serve as acceptable long-term vascular access when AVFs are not possible.
- Careful consideration of vascular access type is essential for optimizing hemodialysis outcomes in children with ESRD.
Abstract:
The aim of our study was to report our experience with arteriovenous fistulas (AVFs) and non-cuffed central venous catheters (CVCs) in children and adolescents with end-stage renal disease (ESRD) on hemodialysis (HD). The children with ESRD (18 years or younger) who were hemodialyzed at the Center of Dialysis and Transplantation, Children's Hospital, Ljubljana, in the period between December 1998 and December 2010 were included in our retrospective study. We recorded the data considering the CVCs and AVFs used for HD. Thirty-one children (13 females, 18 males) with ESRD received HD treatment. The mean patient age when HD was started was 13.3 ± 3.4 years. Altogether, 35 AVFs were created, and the primary failure rate was 25.7% (9/35). The time to maturation was 4.0 ± 2.5 months. The mean patency of the AVF was 42.5 ± 51.9 months. Seventy-seven CVCs (non-cuffed) were inserted in the observation period; 89.6% of the CVCs were inserted in the jugular vein, and citrate locking was used in the interdialysis period. The CVCs were removed after 0.1-17.4 months (3.6 ± 3.7 months). The incidence of bacteremia was 0.9 episodes per 1000 catheter days. The preferred vascular accesses for pediatric hemodialysis are native AVFs; however, a single lumen, non-cuffed, citrate-locked CVC placed in a jugular vein can be acceptable as a long-term vascular access when AVF cannot be constructed or used.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Kidney Transplant III: Nursing Management

